002022-基本财务实时评分详情
科华生物002022基本财务实时评分详情
更新时间:2022-01-22 00:00:01
股票代码
002022
当期评分
股票名称
科华生物
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.24610.48371.44841.44841.4484
销售净利润率(%)12.401411.323225.961225.961225.9612
销售毛利率(%)40.242943.45655.856855.856855.8568
净资产收益率(%)9.548.5913.9613.9613.96
营业增长率(%)24.847521.317245.299245.299245.2992
净利润增长率(%)11.469710.7689152.9497152.9497152.9497
每股收益(%)0.40540.39470.78270.37550.0975
现金流量比率(%)16.905538.277373.830231.40537.1201
三项费用比重(%)24.817227.590822.040225.168526.625
每股净资产(¥)4.22584.58115.59174.97134.6793
流动比率(%)2.34352.79873.35122.47312.6027
速动比率(%)1.66231.96182.56391.81011.8245
现金比率(%)65.323768.0342165.596280.418880.4188
总资产利润率(%)7.9377.585214.72587.74822.1566
主营利润比重%268.092319.1462181.4075208.4827251.5341
应收账款(万元)53,128.6366,290.9672,012.0670,976.8769,963.83
应收票据(万元)225.88--------
预付款项(万元)16,896.6110,454.5013,582.8321,894.4516,964.93
存货(万元)51,094.9254,411.8579,516.1966,736.1660,598.05
在建工程(万元)414.986,326.8610,114.307,773.016,329.18
应付款项(万元)14,690.5020,606.0924,511.5423,498.9920,985.87
长期借款(万元)23,977.1029,417.3022,006.9730,354.5329,223.08
未分配利润(万元)114,935.88128,794.01166,486.41148,910.65133,793.66
商誉(万元)85,599.6785,523.6485,950.6185,871.4885,508.10
流动资产(万元)174,613.92188,518.78196,351.63190,448.06188,774.00
流动负债(万元)74,999.5265,018.11100,989.98100,661.0477,878.31
科华生物002022评分结果
63.64分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006